---
title: "SSRIs - Complete Profile"
substance: "SSRIs"
chemical_name: "Selective Serotonin Reuptake Inhibitors"
category: "Antidepressant"
legal_status: "Prescription medication (Schedule IV for some)"
description: "The most prescribed class of antidepressants - SSRIs revolutionized mental health treatment while creating new controversies about chemical solutions to existential problems"
permalink: "/dyos-domain/substances/ssris/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/nootropics/">Nootropics</a> ‚Üí <span>SSRIs</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üß† SSRIs</h1>
        <h2 class="chemical-name">Selective Serotonin Reuptake Inhibitors</h2>
          <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="SSRIs" 
                data-category="Antidepressants" 
                data-chemical="Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram, Fluvoxamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Common SSRIs & Brand Names</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>First Generation</h4>
              <span>Fluoxetine (Prozac)</span> ‚Ä¢ <span>Sertraline (Zoloft)</span> ‚Ä¢ <span>Paroxetine (Paxil)</span>
            </div>
            <div class="name-category">
              <h4>Second Generation</h4>
              <span>Citalopram (Celexa)</span> ‚Ä¢ <span>Escitalopram (Lexapro)</span> ‚Ä¢ <span>Fluvoxamine (Luvox)</span>
            </div>
            <div class="name-category">
              <h4>Related Classes</h4>
              <span>SNRIs</span> ‚Ä¢ <span>Atypical Antidepressants</span> ‚Ä¢ <span>Tricyclics</span>
            </div>
            <div class="name-category">
              <h4>Street/Slang Terms</h4>
              <span>Happy Pills</span> ‚Ä¢ <span>Vitamin P</span> ‚Ä¢ <span>Antideps</span> ‚Ä¢ <span>Chemical Crutches</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category therapeutic-antidepressant">Therapeutic Antidepressant</span>
          <span class="legal-status prescription">Prescription Required</span>
          <span class="duration chronic">Chronic Use</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/ssris.jpg" alt="Various SSRI pills, serotonin molecule diagram, and brain scan showing increased serotonin activity" class="substance-photo">
          <div class="image-caption">Common SSRI medications (Prozac, Zoloft, Lexapro), serotonin molecular structure, and neuroimaging showing enhanced serotonergic activity - representing the pharmaceutical revolution in treating depression and anxiety disorders</div>
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ Various structures</p>
            <p>Target: SERT protein</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="common-forms">
          <h4>Common SSRI Formulations</h4>
          <ul>
            <li><strong>Fluoxetine (Prozac):</strong> Green/white capsules, various strengths (10-80mg)</li>
            <li><strong>Sertraline (Zoloft):</strong> Light blue tablets, scored, oval-shaped</li>
            <li><strong>Escitalopram (Lexapro):</strong> Round white tablets, various sizes</li>
            <li><strong>Paroxetine (Paxil):</strong> Pink/blue tablets, film-coated</li>
            <li><strong>Citalopram (Celexa):</strong> White to off-white tablets, oval</li>
          </ul>
        </div>
        
        <div class="generic-forms">
          <h4>Generic vs Brand Differences</h4>
          <ul>
            <li><strong>Active ingredient:</strong> Identical between generic and brand</li>
            <li><strong>Inactive ingredients:</strong> May vary (fillers, dyes, coatings)</li>
            <li><strong>Bioequivalence:</strong> Required to be within 80-125% of brand</li>
            <li><strong>Cost difference:</strong> Generics typically 80-90% cheaper</li>
            <li><strong>Appearance:</strong> Generics often different colors/shapes</li>
          </ul>
        </div>
        
        <div class="formulation-types">
          <h4>Available Formulations</h4>
          <ul>
            <li><strong>Immediate release:</strong> Standard tablets/capsules, daily dosing</li>
            <li><strong>Extended release:</strong> Once-daily formulations (Paxil CR)</li>
            <li><strong>Liquid forms:</strong> Oral solutions for children/elderly</li>
            <li><strong>Orally disintegrating:</strong> Dissolves on tongue (some formulations)</li>
          </ul>
        </div>
        
        <div class="safety-note">
          <h4>‚ö†Ô∏è Prescription Verification</h4>
          <p><strong>Always verify with pharmacist:</strong> SSRIs require prescription and medical supervision. Never share psychiatric medications or obtain from non-medical sources.</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="medical-supervision">
        <h4>üè• Medical Supervision Required</h4>
        <p><strong>All SSRI dosing must be supervised by healthcare professionals.</strong> Dosages are highly individualized based on condition, response, side effects, and drug interactions.</p>
      </div>
      
      <div class="dosage-chart therapeutic">
        <h4>Typical Therapeutic Dose Ranges</h4>
        <div class="dose-range fluoxetine">
          <span class="range-label">Fluoxetine (Prozac)</span>
          <span class="dose-amount">20-80mg daily</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range sertraline">
          <span class="range-label">Sertraline (Zoloft)</span>
          <span class="dose-amount">50-200mg daily</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range escitalopram">
          <span class="range-label">Escitalopram (Lexapro)</span>
          <span class="dose-amount">10-20mg daily</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range paroxetine">
          <span class="range-label">Paroxetine (Paxil)</span>
          <span class="dose-amount">20-60mg daily</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range citalopram">
          <span class="range-label">Citalopram (Celexa)</span>
          <span class="dose-amount">20-40mg daily</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Clinical Dosing Considerations</h4>
        <ul>
          <li><strong>Start low, go slow:</strong> Begin with lowest effective dose</li>
          <li><strong>Titration period:</strong> 2-8 weeks to reach therapeutic levels</li>
          <li><strong>Individual variation:</strong> Genetic factors affect metabolism</li>
          <li><strong>Age considerations:</strong> Lower doses for elderly patients</li>
          <li><strong>Kidney/liver function:</strong> Dose adjustments may be needed</li>
          <li><strong>Pregnancy/nursing:</strong> Special dosing considerations</li>
        </ul>
      </div>
      
      <div class="timeline-expectations">
        <h4>Treatment Timeline</h4>
        <ul>
          <li><strong>Week 1-2:</strong> Side effects appear before benefits</li>
          <li><strong>Week 2-4:</strong> Gradual mood improvement begins</li>
          <li><strong>Week 4-8:</strong> Full therapeutic effects typically achieved</li>
          <li><strong>Long-term:</strong> Maintenance therapy often 6+ months</li>
        </ul>
      </div>
      
      <p class="dosage-note medical"><strong>Medical Note:</strong> SSRIs are not recreational drugs. They require weeks to months to achieve therapeutic effects and should only be used under medical supervision for diagnosed conditions.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Therapeutic Timeline</h4>
        <div class="timeline-item">
          <span class="time">Day 1-7</span>
          <span class="effect">Side effects onset - nausea, headache, activation</span>
        </div>
        <div class="timeline-item">
          <span class="time">Week 2-4</span>
          <span class="effect">Early benefits - reduced anxiety, improved sleep</span>
        </div>
        <div class="timeline-item">
          <span class="time">Week 4-8</span>
          <span class="effect">Full effect - mood stabilization, cognitive improvement</span>
        </div>
        <div class="timeline-item">
          <span class="time">Maintenance</span>
          <span class="effect">Sustained benefits with continued use</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category therapeutic">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Reduced depressive symptoms</li>
            <li>Decreased anxiety and panic</li>
            <li>Improved mood stability</li>
            <li>Better sleep regulation</li>
            <li>Reduced rumination and worry</li>
            <li>Enhanced emotional resilience</li>
            <li>Improved social functioning</li>
            <li>Reduced obsessive-compulsive symptoms</li>
          </ul>
        </div>
        
        <div class="effect-category side-effects">
          <h4>‚ùå Common Side Effects</h4>
          <ul>
            <li>Nausea and gastrointestinal upset</li>
            <li>Sexual dysfunction (decreased libido, anorgasmia)</li>
            <li>Weight gain or loss</li>
            <li>Insomnia or sedation</li>
            <li>Headaches</li>
            <li>Dry mouth</li>
            <li>Tremor and restlessness</li>
            <li>Emotional blunting</li>
          </ul>
        </div>
      </div>

      <div class="acute-effects">
        <h4>‚ö†Ô∏è Acute/Initial Effects</h4>
        <p><strong>Activation syndrome:</strong> First 1-2 weeks may include increased anxiety, agitation, insomnia, and in rare cases, suicidal ideation (especially in young adults under 25). Close monitoring essential during initiation.</p>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>SSRIs selectively inhibit the serotonin transporter (SERT), blocking reuptake of serotonin from synaptic clefts. This increases synaptic serotonin availability and enhances serotonergic neurotransmission. The therapeutic effects are thought to result from downstream neuroplastic changes including increased BDNF expression, hippocampal neurogenesis, and synaptic remodeling.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>SERT (5-HT transporter)</strong></span>
            <span class="affinity">High selectivity, Ki: 0.1-10 nM</span>
            <span class="function">Primary therapeutic target, increased synaptic 5-HT</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2A/2C receptors</strong></span>
            <span class="affinity">Indirect activation via increased 5-HT</span>
            <span class="function">Anxiety, sleep disruption, sexual side effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT3 receptors</strong></span>
            <span class="affinity">Indirect activation</span>
            <span class="function">Nausea, gastrointestinal side effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT1A autoreceptors</strong></span>
            <span class="affinity">Desensitization over time</span>
            <span class="function">Delayed therapeutic response (2-8 weeks)</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Other transporters</strong></span>
            <span class="affinity">Minimal NET/DAT affinity</span>
            <span class="function">Selectivity vs tricyclics, fewer side effects</span>
          </div>
        </div>

        <h4>Neuroplasticity Mechanisms</h4>
        <div class="neuroplasticity-details">
          <p><strong>BDNF upregulation:</strong> Increased brain-derived neurotrophic factor promotes neurogenesis</p>
          <p><strong>Hippocampal neurogenesis:</strong> New neuron formation in memory/mood centers</p>
          <p><strong>Synaptic plasticity:</strong> Enhanced long-term potentiation and learning</p>
          <p><strong>HPA axis normalization:</strong> Reduced stress hormone dysregulation</p>
          <p><strong>Default mode network:</strong> Altered connectivity in depression-associated brain networks</p>
        </div>

        <h4>Pharmacokinetics by Drug</h4>
        <div class="pharmacokinetics-table">
          <div class="pk-row">
            <span class="drug-name">Fluoxetine (Prozac)</span>
            <span class="half-life">1-3 days (active metabolite: 4-16 days)</span>
            <span class="metabolism">CYP2D6, long-acting</span>
          </div>
          <div class="pk-row">
            <span class="drug-name">Sertraline (Zoloft)</span>
            <span class="half-life">22-36 hours</span>
            <span class="metabolism">CYP2B6, moderate half-life</span>
          </div>
          <div class="pk-row">
            <span class="drug-name">Paroxetine (Paxil)</span>
            <span class="half-life">15-20 hours</span>
            <span class="metabolism">CYP2D6, shortest half-life</span>
          </div>
          <div class="pk-row">
            <span class="drug-name">Escitalopram (Lexapro)</span>
            <span class="half-life">27-32 hours</span>
            <span class="metabolism">CYP2C19, cleanest profile</span>
          </div>
          <div class="pk-row">
            <span class="drug-name">Citalopram (Celexa)</span>
            <span class="half-life">35 hours</span>
            <span class="metabolism">CYP2C19, cardiac concerns at high doses</span>
          </div>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Delayed therapeutic response:</strong> 2-8 weeks due to receptor adaptation</li>
          <li><strong>Selectivity advantage:</strong> Fewer anticholinergic/antihistaminergic effects vs tricyclics</li>
          <li><strong>Individual variation:</strong> CYP enzyme polymorphisms affect response</li>
          <li><strong>Discontinuation effects:</strong> Withdrawal syndrome with rapid cessation</li>
          <li><strong>Drug interactions:</strong> CYP inhibition affects other medication metabolism</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Medical Considerations</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Suicidal ideation:</strong> Increased risk in under-25s during first weeks</li>
            <li><strong>Serotonin syndrome:</strong> Dangerous with MAOIs, tramadol, other serotonergics</li>
            <li><strong>QT prolongation:</strong> Cardiac risk with citalopram at high doses</li>
            <li><strong>Hyponatremia:</strong> Low sodium, especially in elderly</li>
            <li><strong>Bleeding risk:</strong> Increased with anticoagulants/NSAIDs</li>
          </ul>
        </div>
        
        <div class="safety-item monitoring">
          <h4>üîç Required Monitoring</h4>
          <ul>
            <li>Regular psychiatric evaluation</li>
            <li>Suicide risk assessment (especially initial weeks)</li>
            <li>Blood pressure and weight monitoring</li>
            <li>Liver function tests (if indicated)</li>
            <li>Electrolyte monitoring in elderly</li>
            <li>Sexual function assessment</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications & Cautions</h4>
        <ul>
          <li><strong>MAOI use:</strong> 2-week washout period required</li>
          <li><strong>Bipolar disorder:</strong> Risk of inducing mania</li>
          <li><strong>Severe liver disease:</strong> Dose adjustment needed</li>
          <li><strong>Cardiac conditions:</strong> QT interval monitoring</li>
          <li><strong>Pregnancy:</strong> Risk-benefit analysis required</li>
          <li><strong>Angle-closure glaucoma:</strong> Increased intraocular pressure</li>
        </ul>
      </div>

      <div class="withdrawal-syndrome">
        <h4>‚ö†Ô∏è Discontinuation Syndrome</h4>
        <p><strong>SSRI withdrawal effects:</strong> Dizziness, flu-like symptoms, electric shock sensations, mood changes. Requires gradual tapering over weeks to months. Paroxetine has highest withdrawal risk due to short half-life.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Contraindicated</h4>
          <ul>
            <li><strong>MAOIs:</strong> Serotonin syndrome, potentially fatal</li>
            <li><strong>Linezolid:</strong> Antibiotic with MAOI activity</li>
            <li><strong>Methylene blue:</strong> IV form has MAOI properties</li>
            <li><strong>Pimozide:</strong> QT prolongation with some SSRIs</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Tramadol:</strong> Serotonin syndrome risk</li>
            <li><strong>Triptans:</strong> Serotonin syndrome (sumatriptan, etc.)</li>
            <li><strong>SNRIs/TCAs:</strong> Additive serotonergic effects</li>
            <li><strong>St. John's Wort:</strong> Serotonin syndrome</li>
            <li><strong>Anticoagulants:</strong> Increased bleeding risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Monitor Closely</h4>
          <ul>
            <li><strong>NSAIDs:</strong> GI bleeding and reduced antidepressant efficacy</li>
            <li><strong>CYP2D6 substrates:</strong> Metabolic interactions</li>
            <li><strong>Beta-blockers:</strong> Altered metabolism</li>
            <li><strong>Alcohol:</strong> Increased sedation, cognitive impairment</li>
          </ul>
        </div>
      </div>

      <div class="cyp-interactions">
        <h4>üß¨ CYP Enzyme Interactions</h4>
        <p>SSRIs inhibit various CYP enzymes, affecting metabolism of other drugs. Fluoxetine and paroxetine are strong CYP2D6 inhibitors, while fluvoxamine strongly inhibits CYP1A2. This can lead to dangerous accumulation of co-administered medications.</p>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Prescription required</strong> - DEA scheduling varies by specific drug. Most are unscheduled prescription medications, though some (like fluvoxamine) may be Schedule IV.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Prescription-only medicines (POM)</strong> - Available only through NHS or private prescription. Controlled access through healthcare system.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Prescription required</strong> - Regulated as prescription medications across EU. Availability and pricing vary by country's healthcare system.</p>
          </div>
          <div class="jurisdiction">
            <h4>üåç Global Status</h4>
            <p><strong>Widely available</strong> - Most SSRIs are approved globally but require medical prescription. Generic availability has improved access.</p>
          </div>
        </div>
        
        <div class="regulatory-status">
          <h4>üè• Regulatory History</h4>
          <p>SSRIs underwent extensive clinical trials for FDA approval. Post-marketing surveillance led to black box warnings for suicidal ideation in young adults. Ongoing regulatory scrutiny regarding long-term effects and withdrawal.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1970s</span>
          <p>Early research on serotonin's role in depression leads to SSRI development</p>
        </div>
        <div class="history-event">
          <span class="year">1987</span>
          <p>Fluoxetine (Prozac) becomes first SSRI approved by FDA</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>"Prozac Nation" - cultural phenomenon, mass adoption of antidepressants</p>
        </div>
        <div class="history-event">
          <span class="year">1991-1999</span>
          <p>Rapid approval of other SSRIs: sertraline, paroxetine, fluvoxamine, citalopram</p>
        </div>
        <div class="history-event">
          <span class="year">2004</span>
          <p>FDA black box warning for increased suicidal thoughts in young adults</p>
        </div>
        <div class="history-event">
          <span class="year">2002</span>
          <p>Escitalopram (Lexapro) approved as "improved" version of citalopram</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Patent expirations lead to widespread generic availability</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Impact</h4>
        <p>SSRIs fundamentally changed how society views depression and mental health treatment. The "Prozac revolution" normalized psychiatric medication use but also sparked debates about medicalization of normal human emotions. These drugs enabled millions to function but raised questions about authentic selfhood and pharmaceutical solutions to existential problems.</p>
      </div>

      <div class="societal-changes">
        <h4>Societal Changes</h4>
        <ul>
          <li><strong>Destigmatization:</strong> Made depression treatment more socially acceptable</li>
          <li><strong>Mass adoption:</strong> Over 40 million Americans currently take antidepressants</li>
          <li><strong>Cultural debates:</strong> "Chemical imbalance" theory vs. social/psychological causes</li>
          <li><strong>Economic impact:</strong> Multi-billion dollar market, reduced disability costs</li>
          <li><strong>Treatment paradigm:</strong> Shifted focus from psychotherapy to pharmacotherapy</li>
        </ul>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Treatment-Resistant Depression</h4>
          <p>Research into SSRI augmentation strategies, including ketamine, psilocybin, and novel compounds for patients who don't respond to first-line treatments.</p>
        </div>
        
        <div class="research-item">
          <h4>Personalized Medicine</h4>
          <p>Pharmacogenomic testing to predict SSRI response based on CYP enzyme variants, potentially improving treatment selection and reducing trial-and-error prescribing.</p>
        </div>
        
        <div class="research-item">
          <h4>Long-term Effects</h4>
          <p>Ongoing studies examining the consequences of chronic SSRI use, including effects on bone density, sexual function, and cognitive performance over decades.</p>
        </div>
        
        <div class="research-item">
          <h4>Discontinuation Protocols</h4>
          <p>Research into optimal tapering schedules and interventions to minimize withdrawal symptoms, recognizing that many patients struggle to discontinue SSRIs.</p>
        </div>
        
        <div class="research-item">
          <h4>Neuroplasticity Mechanisms</h4>
          <p>Advanced neuroimaging studies examining how SSRIs promote brain plasticity and whether these changes persist after discontinuation.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Resources</h4>
        <ul>
          <li><a href="https://www.mayoclinic.org/">Mayo Clinic</a> - Comprehensive medical information</li>
          <li><a href="https://medlineplus.gov/">MedlinePlus</a> - NIH consumer health information</li>
          <li><a href="https://www.fda.gov/">FDA</a> - Official drug safety information</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Mental Health Support</h4>
        <ul>
          <li><a href="https://www.nami.org/">NAMI</a> - National Alliance on Mental Illness</li>
          <li><a href="https://suicidepreventionlifeline.org/">988 Suicide & Crisis Lifeline</a></li>
          <li><a href="https://www.samhsa.gov/">SAMHSA</a> - Mental health services locator</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Research & Information</h4>
        <ul>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - Scientific literature</li>
          <li><a href="https://www.cochrane.org/">Cochrane Reviews</a> - Evidence-based medicine</li>
          <li><a href="https://www.survivingantidepressants.org/">Surviving Antidepressants</a> - Withdrawal support</li>
        </ul>
      </div>
    </div>
  </div>

</div>